n South African Medical Journal - Clinical Access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis : forum - clinical practice
|Article Title||Clinical Access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis : forum - clinical practice|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||South African Medical Journal|
|Affiliations||1 University of the Witwatersrand, 2 University of Cape Town, 3 University of Cape Town, 4 Medecins Sans Frontieres, 5 Klerksdorp/Tshepong Complex, 6 Brooklyn Chest Hospital, 7 King Dinuzulu Hospital Complex and 8 National Department of Health|
|Publication Date||Mar 2014|
|Pages||164 - 166|
While clinical disease caused by drug-sensitive Mycobacterium tuberculosis (MTB) can usually be treated successfully, clinical disease caused by drug-insensitive MTB is associated with a poorer prognosis. In December 2012, a new drug, bedaquiline, was approved by the US Food and Drug Administration. This article documents the process whereby the National Department of Health, Right to Care and Médecins Sans Frontières obtained access to this medication for South Africans who might benefit from subsequent implementation of the Clinical Access to Bedaquiline Programme.
Article metrics loading...